Rutgers, The State University of New Jersey: Melanoma trials
The registry lists 10 Melanoma studies with Rutgers, The State University of New Jersey as lead sponsor. 2 are open to participants now and 4 have results posted.
Early Phase 1 1Phase 1 2Phase 2 3No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.RecruitingNCT07830225Not applicable
- MySmartSkin Online Skin Self-exam Intervention for Melanoma SurvivorsRecruitingNCT05373823Not applicable
- Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or LymphomaCompletedNCT03229278Phase 1Results posted
- Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With MelanomaCompletedNCT03028948Not applicableResults posted
- Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV MelanomaTerminatedNCT02748564Phase 2Results posted
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT00866840Phase 2Results posted
- Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for MelanomaCompletedNCT03725449Not applicable
- Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersCompletedNCT03112668Not applicable
- Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by SurgeryCompletedNCT00962845Early Phase 1
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerStatus unknownNCT00553683Phase 1/2